Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Ciurea

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
Rheumatology (Oxford, England)|September 2, 2017
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritisDeshiré Alpizar-Rodriguez, Rüdiger B Mueller, Burkhard Möller, et al.
Scientific Reports|October 18, 2023
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical careMyriam Riek, Almut Scherer, Burkhard Möller, et al.
RMD Open|June 23, 2026
Site-specific articular responses to b/tsDMARDs in rheumatoid arthritis: a longitudinal observational study from the Swiss Clinical Quality Management RegistryAnnik Steimer, Andrea Götschi, Jonas Brändli, et al.
Frontiers in Immunology|October 31, 2022
Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseasesCatherine E Raptis, Christoph T Berger, Adrian Ciurea, et al.
Annals of the Rheumatic Diseases|September 24, 2017
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohortChristoph Molnar, Almut Scherer, Xenofon Baraliakos, et al.
RMD Open|March 5, 2026
Effectiveness of TNF inhibitors in patients with very early axial spondyloarthritis, defined as duration of ≤1 year of back pain: longitudinal observational data from the SCQM registryMauro Bachmann, Andrea Götschi, Annik Steimer, et al.
Arthritis and Rheumatism|August 29, 2013
Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohortAdrian Ciurea, Almut Scherer, Pascale Exer, et al.
Rheumatology (Oxford, England)|March 17, 2019
Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort studySilja Bühler, Veronika Katharina Jaeger, Sabine Adler, et al.
The Journal of Rheumatology|February 17, 2018
Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss CohortMonika Hebeisen, Regula Neuenschwander, Almut Scherer, et al.
RMD Open|November 28, 2025
Identification of individuals at high risk of developing rheumatoid arthritis: a balanced random forest model in a cohort of 1544 first-degree relativesRomain Aymon, Céline Lamacchia, Benoit Thomas P Gilbert, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Rheumatology (Oxford, England)|September 2, 2017
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritisDeshiré Alpizar-Rodriguez, Rüdiger B Mueller, Burkhard Möller, et al.
Scientific Reports|October 18, 2023
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical careMyriam Riek, Almut Scherer, Burkhard Möller, et al.
RMD Open|June 23, 2026
Site-specific articular responses to b/tsDMARDs in rheumatoid arthritis: a longitudinal observational study from the Swiss Clinical Quality Management RegistryAnnik Steimer, Andrea Götschi, Jonas Brändli, et al.
Frontiers in Immunology|October 31, 2022
Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseasesCatherine E Raptis, Christoph T Berger, Adrian Ciurea, et al.
Annals of the Rheumatic Diseases|September 24, 2017
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohortChristoph Molnar, Almut Scherer, Xenofon Baraliakos, et al.
RMD Open|March 5, 2026
Effectiveness of TNF inhibitors in patients with very early axial spondyloarthritis, defined as duration of ≤1 year of back pain: longitudinal observational data from the SCQM registryMauro Bachmann, Andrea Götschi, Annik Steimer, et al.
Arthritis and Rheumatism|August 29, 2013
Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohortAdrian Ciurea, Almut Scherer, Pascale Exer, et al.
Rheumatology (Oxford, England)|March 17, 2019
Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort studySilja Bühler, Veronika Katharina Jaeger, Sabine Adler, et al.
The Journal of Rheumatology|February 17, 2018
Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss CohortMonika Hebeisen, Regula Neuenschwander, Almut Scherer, et al.
RMD Open|November 28, 2025
Identification of individuals at high risk of developing rheumatoid arthritis: a balanced random forest model in a cohort of 1544 first-degree relativesRomain Aymon, Céline Lamacchia, Benoit Thomas P Gilbert, et al.
Pageof 13